by McDermott + Bull | Nov 22, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Jake Vander Zanden, Jake Vander Zanden Article
2022 has been an interesting year for life sciences and executive search. We have finally been able to attend in-person conferences and events without the looming fear of the COVID-19 pandemic hanging over our heads. In October, Jessica Combs and I attended the...
by McDermott + Bull | Oct 3, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga, Placement Announcement
McDermott +Bull has successfully placed Gary Counter as Senior Vice President, Sales at Nihon Kohden. Gary will be responsible for the company’s scalability and cohesion by integrating, building, and creating the right teams, processes, and technologies. Gary is an...
by McDermott + Bull | Oct 3, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Michael Matranga, Placement Announcement
McDermott +Bull has successfully placed Hagit Jarne-Goldshtain as Vice President, Marketing at Nihon Kohden. Working closely with the CEO and the Head of Sales, Hagit will oversee the design and execution of the organization’s product and brand marketing strategy. She...
by McDermott + Bull | Aug 19, 2022 | Jake Vander Zanden, Let's Chat
In my recent conversations with senior leaders, I’ve noticed there is a lot of talk about digital transformation, and many CEOs are struggling to figure out where they fit within this. The CEO’s responsibility is to serve as the heartbeat of an organization, driving...
by McDermott + Bull | Aug 15, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Kevin Belteau as Vice President (VP) of Clinical Affairs at enVVeno Medical. Kevin will develop, implement, and execute the company’s U.S. clinical trial strategy, ensuring the highest possible performance of clinical affairs...
by McDermott + Bull | Aug 1, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Placement Announcement, Jake Vander Zanden, Jake Vander Zanden Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Dr. Susan Daniels as Chief Scientific Officer at Avellino Labs. In her new role, Susan will work with the company’s Founder and Chairman to set the scientific direction of the company in developing new diagnostic tools and...
